Saji Wickramasekara

Sajith Wickramasekara, CEO and co-founder of Benchling, transforms biotech workflows through innovative software solutions. He shares insights on the evolution of biotechnology and the crucial role of AI in drug discovery. Saji reveals how structured data can supercharge scientific research, addressing the challenges in integrating modern technology into pharma. He also discusses navigating competition and the startup journey, emphasizing the importance of understanding customer needs in a rapidly changing landscape.

Sajith Wickramasekara, CEO and co-founder of Benchling, revolutionizes scientific efficiency with a cloud-based platform. He shares his journey into life sciences and discusses the promise of immunotherapy and breakthroughs in gene therapy. The ethics of editing human embryos sparks a heated debate, distinguishing legitimate advancements from quackery. Insights into genetically modified crops and their implications for health provide a well-rounded view of the future in biotechnology. It's a thought-provoking conversation about the intersection of science, morality, and innovation.